---
title: "LAMPERT MARK N — Ownership Dossier"
canonical: https://whiteintel.dev/entity/88b59549-d5c2-569d-a163-bc9f5aadeb62
json: https://whiteintel.dev/api/public/dossier/88b59549-d5c2-569d-a163-bc9f5aadeb62
identifier: sec:0001233840
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LAMPERT MARK N

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001233840`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/88b59549-d5c2-569d-a163-bc9f5aadeb62  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/88b59549-d5c2-569d-a163-bc9f5aadeb62  

## Ownership & control

### Holdings / subsidiaries

- **XOMA Royalty Corp** (10% owner) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **Kymera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **Kymera Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **Olema Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **MoonLake Immunotherapeutics** (tenpercentowner) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **XOMA Royalty Corp** (tenpercentowner) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **MoonLake Immunotherapeutics** (director) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **IMMUNIC, INC.** (other) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51
- **Repare Therapeutics Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a4f328c3-615d-5e8c-a160-a31e92a6143d
- **IMMUNIC, INC.** (director) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51

…and **83** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **LAMPERT MARK N** — https://whiteintel.dev/entity/88b59549-d5c2-569d-a163-bc9f5aadeb62 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LAMPERT MARK N**. Human view: https://whiteintel.dev/entity/88b59549-d5c2-569d-a163-bc9f5aadeb62 · Structured JSON: https://whiteintel.dev/api/public/dossier/88b59549-d5c2-569d-a163-bc9f5aadeb62._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._